TARLATAMAB TRAS LA APROBACIÓN COMPLETA EN ESTADOS UNIDOS PARA EL TRATAMIENTO SMALL CELL LUNG CANCER EXTENSIVE-STAGE ... AHORA LE TOCA EL TURNO DE CONSEGUIR LA FULL APPROVAL EN EUROPA ... LA EMA PODRÍA DAR SU BENDICIÓN EN LA REUNIÓN DE MARZO .
... Belgium-based TiGenix raised $36 million on the sale of 2.3 million ADSs at a 14% discount to the converted price of the Euronext-listed shares. Its first day drop of 24.5% was the worst first-day performance of the year.